A Retrospective Study of Carcinoma Esophagus in Western Rajasthan
Authors/Creators
- 1. Department of General Surgery, SN Medical College Jodhpur, Rajasthan
- 2. SCB medical college & Hospital Cuttack, Odisha
Description
Background: Esophageal cancer is a deadly malignancy with a very low survival. Esophageal cancer is the 6th most common cancer and cause of cancer-related deaths in India. Objectives: To evaluate the incidence, clinical profile and varies treatment modality in esophageal cancer in the western Rajasthan population. Materials and Methods: This retrospective analytic study was conducted in Department of General Surgery at M. G. Hospital attached to Dr S. N. Medical College, Jodhpur. A total of 32 patients with Esophageal Cancer were registered in the 8 year duration. The socio-demographic parameters including age, gender, locality, socioeconomic status, religion, education, occupation, and the addiction patterns of the patients were studied. All the patients were treated with the standard protocol. Results: Out of 35 patients, 43.75 % were males and 56.25 % female. Male: female ratio in study was (0.77:1). The age were range from 21-73 years, the incidence was highest in 5th decade followed by 6th and 7th decade in the study patients. The most common symptom was dysphagia. In management Surgical resection (35.48%), Surgical resection + chemo / RT or both (16.12%), palliative resection and chemoradiotherapy (3.22%) , Feeding jejunostomy ± chemo / RT or both (25.90%) was done. longest survival period was 18 month as reported in our study. Conclusion: Esophageal carcinoma is important cancers prevalent in western Rajasthan, with peak incidence was in 5th decade of life. Multimodality treatment is advocate in young patients with advanced disease. Surgical resection was the mainstay of treatment in absence of systemic metastasis. Terminally ill patients were treated by palliative measures like feeding jejunostomy / stenting.
Abstract (English)
Background: Esophageal cancer is a deadly malignancy with a very low survival. Esophageal cancer is the 6th most common cancer and cause of cancer-related deaths in India. Objectives: To evaluate the incidence, clinical profile and varies treatment modality in esophageal cancer in the western Rajasthan population. Materials and Methods: This retrospective analytic study was conducted in Department of General Surgery at M. G. Hospital attached to Dr S. N. Medical College, Jodhpur. A total of 32 patients with Esophageal Cancer were registered in the 8 year duration. The socio-demographic parameters including age, gender, locality, socioeconomic status, religion, education, occupation, and the addiction patterns of the patients were studied. All the patients were treated with the standard protocol. Results: Out of 35 patients, 43.75 % were males and 56.25 % female. Male: female ratio in study was (0.77:1). The age were range from 21-73 years, the incidence was highest in 5th decade followed by 6th and 7th decade in the study patients. The most common symptom was dysphagia. In management Surgical resection (35.48%), Surgical resection + chemo / RT or both (16.12%), palliative resection and chemoradiotherapy (3.22%) , Feeding jejunostomy ± chemo / RT or both (25.90%) was done. longest survival period was 18 month as reported in our study. Conclusion: Esophageal carcinoma is important cancers prevalent in western Rajasthan, with peak incidence was in 5th decade of life. Multimodality treatment is advocate in young patients with advanced disease. Surgical resection was the mainstay of treatment in absence of systemic metastasis. Terminally ill patients were treated by palliative measures like feeding jejunostomy / stenting.
Files
IJTPR,Vol12,Issue1,Article28.pdf
Files
(169.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ce86643282cfe3552626dcccb5cedad1
|
169.7 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-01-30
Software
References
- 1. Cherian JV, Sivaraman R, Muthusamy AK, et al. Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center. J Gastrointestin Liver Dis 2007;16:245-9. 2. Globocan 2008, accessed online at http://globocan.iarc.fr/factsheet.asp on 9th December, 2012 3. Rasool S, A Ganai B, Syed Sameer A, Masood A Tumori. Esophageal cancer: associated factors with special reference to the Kashmir Valley. 2012 Mar-Apr; 98(2):191-203. 4. Bosetti C, Levi F, Ferlay J, et al. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2008 Mar 1;122: 1118-29. 5. Crew KD, Neugut AI: Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31:450-464, 2004. 6. Lagergren J: Adenocarcinoma of esophagus: Gut 54 (Suppl 1): i1-i5, 2005. 7. Portale G, Peters JH, Hsieh CC, et al: Esophageal adenocarcinoma in patients < or = 50 years old: Delayed diagnosis and advanced disease at presentation. Am Surg 70:954-958, 2004. 8. Kubo A, Corley DA: Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99:582-588, 2004. 9. Daly JM, Fry WA, Little AG, et al: Esophageal cancer: Result of an American College of Surgeons Patient Care Evaluation Study. Am Coll Surg 190: 562-572, 2000. 10. Steve Gold Schmid et al. (1994) : Gastro int. endo. Clini of North America, Vol 4, No 4, 827-850. 11. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection of esophageal adenocarcinoma: Analysis of 100 en block esophagectomies. Ann Surg2001; 234: 520-530. 12. Altorki N, kent M, Ferrara C, Port J. Three field lymph node dissection SCC and adenocarcinoma of esophagus. Ann Surg 2002; 236:177-183. 13. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous cell carcinoma durinngg 15 consecutive years. Ann Surg 2000; 232:225-232. 14. Ramirez FC, Dennert B, Zierer ST:Esophageal SEMS indications, practice, techniques and complications: Results of a national survey. Gastrointest Endosac 45: 360-364, 1997. 15. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981;153:690-692 16. Fok M, McShane J, Law SY, Wong J. A prospective randomaized study on radiotherapy and surgery in the treatment of oesophageal carcinoma. Symposium on esophagaeal carcinoma in the Asianpacific rim. Asian J Surg 1994; 17: 223- 229 17. Teniere P, Hay J-M, Fingerhut A, Fagniez P-L. Postoperative radiation therapy doas not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by multicenter controlled trial. Surg Gynecol Obstet 1991; 173: 123-130 18. Fok M, Sham JS, Choy D, Cheng SW, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993; 113: 138- 147 19. Xiao ZF, Yang ZY, Liang J, et ai. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003; 75: 331- 336 20. Urba SG, Orringer MB, Turrisi A, et al: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305-313, 2001. 21. Rice TW, Adelstein DJ, Chidel MA, et al: Benefit of postoperative adjuvant chemotherapy in locoregionally advanced esophageal carcinoma. J thorac Cardiovasc Surg 126:1590-1596, 2003. 22. Portale G, Hagen JA, Peters JH, et al:Modern 5 year survival in respectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 202: 588-596.